There is no vaccine for mono, and the virus that causes it is remarkably hard to avoid. About 90% of adults worldwide carry Epstein-Barr virus (EBV), the pathogen behind infectious mononucleosis, and many of them can spread it without ever knowing they’re infected. Prevention comes down to reducing your exposure to saliva and other body fluids from people who may be shedding the virus, even when they look and feel perfectly healthy.
How Mono Spreads
EBV travels primarily through saliva. Kissing is the most direct route, which is why mono picked up the nickname “the kissing disease.” But saliva gets around in less obvious ways too: sharing water bottles, drinking glasses, eating utensils, toothbrushes, and food. Young children spread it by drooling on toys that other kids then put in their mouths. The virus can also spread through blood and semen during sexual contact, and less commonly through blood transfusions and organ transplants.
EBV can survive on surfaces at room temperature for several days. A shared water bottle left on a dorm room desk or a fork at a dining hall isn’t instantly safe just because a few hours have passed.
Why Avoiding It Is So Difficult
The biggest challenge with mono prevention is that people shed the virus long after they feel fine. According to the World Health Organization, EBV can remain active in your saliva for six months or longer after symptoms disappear. And that’s just people who had noticeable symptoms in the first place.
A six-month study tracking healthy adults with no symptoms found that every single EBV-positive participant shed viral DNA from their mouth at some point during the study period. Across all samples collected, about 24% tested positive for the virus. Adults between 18 and 30 shed the virus significantly more often than older adults, likely because less time had passed since their initial infection. This means the college-age population most vulnerable to mono is also surrounded by the people most likely to be silently spreading it.
Practical Steps That Reduce Your Risk
Since you can’t tell who is shedding EBV, prevention is about changing everyday habits rather than avoiding specific people.
- Don’t share drinks or water bottles. This is the single most common non-kissing transmission route, especially among college students and athletes. Bring your own bottle and keep it labeled.
- Use your own utensils and dishes. Sharing forks, spoons, or bites of food transfers saliva directly.
- Never share a toothbrush. This sounds obvious, but it happens more often than you’d think in shared living spaces.
- Skip sharing lip balm or lipstick. Anything that touches your mouth and then someone else’s is a potential vehicle for EBV.
- Wash your hands regularly. Soap and water won’t prevent every transmission, but it reduces the viral load you pick up from contaminated surfaces.
- Avoid kissing someone who currently has or recently had mono. If a partner, friend, or family member was diagnosed, the virus can linger in their saliva for months after recovery. Kaiser Permanente recommends avoiding saliva-sharing contact for at least several weeks after diagnosis, though the risk extends well beyond that window.
College Campuses and Close Living Quarters
Mono peaks in adolescents and young adults, and college dorms create ideal conditions for it to spread. Students share water bottles, pass around slices of pizza, eat from the same containers, and live in tight spaces where personal items get mixed up. The virus doesn’t need a romantic kiss to find a new host. A communal cup at a party or a teammate’s water bottle at practice is enough.
The practical reality, as physicians who treat college students acknowledge, is that most young adults won’t follow prevention advice perfectly. But even partial adherence helps. Keeping your own water bottle, not eating directly off someone else’s plate, and getting enough sleep to keep your immune system functioning all lower the odds. Sleep deprivation and stress, both common in college, weaken your body’s ability to fight off a new infection if you are exposed.
If Someone Near You Has Mono
When a roommate, partner, or close friend is diagnosed, you’re most at risk while they still have symptoms like fever, sore throat, and fatigue. But the contagious window extends for six months or more after those symptoms clear. During that time, avoid sharing anything that touches their mouth. Wash shared dishes and utensils with hot water and soap. EBV doesn’t survive standard cleaning, so wiping down surfaces and running dishes through a normal wash cycle is sufficient.
If you develop symptoms yourself, the standard rapid test for mono (called a heterophile antibody test or monospot) can miss early infections and is less reliable in young children. More specific blood tests that look for EBV antibodies are highly accurate, with studies showing 100% agreement with confirmed acute infections. If your rapid test comes back negative but you still feel sick, your doctor can order the more detailed version.
Once You’ve Had It, You’re Protected
After your body fights off the initial EBV infection, you develop lasting immunity against mono. The virus stays dormant in your system for life, but it almost never causes a second episode of mononucleosis in people with healthy immune systems. Reactivation can occasionally happen in people with severely weakened immune systems, such as organ transplant recipients, but this is a different clinical situation than a typical case of mono.
This lifelong immunity is also why many people never get mono despite being exposed constantly. If you were infected as a young child, which is common and usually causes no symptoms at that age, you already carry protection. Most cases of symptomatic mono occur in teenagers and young adults encountering EBV for the first time.
No Vaccine Yet
Despite decades of effort, no EBV vaccine has made it to market. The most advanced candidate, a protein-based vaccine tested in a large clinical trial, reduced symptomatic mono by 78% but did not prevent the underlying EBV infection itself. Newer approaches using mRNA and nanoparticle technology have shown promise in animal studies but haven’t yet been tested in people. For now, behavioral prevention remains the only option.